Arab World vs Ireland: Access to anti-retroviral drugs, male
Arab World
49.3%
in 2024
Ireland
89.0%
in 2023
Arab World rank
16th
Ireland rank
17th
Access to anti-retroviral drugs, male over time
- Arab World
- Ireland
How they compare
Ireland currently reports 89.0% against 49.3% in Arab World, a difference of 39.7%.
That makes Ireland's figure about 1.8 times Arab World's.
Across all 24 years both countries report, Ireland has been ahead every year.
Arab World ranks 16th and Ireland ranks 17th of 19 groups.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 47.1% | 40.2% | Ireland |
| 2010s | 24.3% | 71.4% | 47.1% | Ireland |
| 2020s | 43.0% | 87.5% | 44.5% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Arab World or Ireland?
- Ireland, at 89.0% against 49.3% in Arab World as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Arab World and Ireland?
- 39.7%, with Ireland ahead.
- How many years of comparable data are there for Arab World and Ireland?
- 24 years are reported by both, from 2000 to 2023.
- How do Arab World and Ireland rank globally for access to anti-retroviral drugs, male?
- Arab World ranks 16th and Ireland ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.